BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29976595)

  • 1. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.
    Richter SE; Miller L; Uslan DZ; Bell D; Watson K; Humphries R; McKinnell JA
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for development of aminoglycoside resistance among gram-negative rods.
    Richter SE; Miller L; Needleman J; Uslan DZ; Bell D; Watson K; Humphries R; McKinnell JA
    Am J Health Syst Pharm; 2019 Oct; 76(22):1838-1847. PubMed ID: 31665763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin Susceptibility Testing by Colistin Broth Disk Elution MIC Method among Carbapenem-resistant Gram-negative Blood Culture Clinical Isolates in a Tertiary Care Setting, East Delhi, India.
    Nirmal K; Singh NP; Sarkar K; Goyal N; Gangar S; Dwivedi AN
    Ethiop J Health Sci; 2023 Sep; 33(5):743-750. PubMed ID: 38784504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Tanfous FB; Raddaoui A; Chebbi Y; Achour W
    Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit.
    Maina JW; Mutua JM; Musyoki AM
    BMC Infect Dis; 2024 May; 24(1):522. PubMed ID: 38783175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.
    Kaza P; Mahindroo J; Veeraraghavan B; Mavuduru RS; Mohan B; Taneja N
    J Med Microbiol; 2019 Jun; 68(6):837-847. PubMed ID: 31084700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
    Singh SK; Gupta M
    Microb Pathog; 2016 Nov; 100():75-77. PubMed ID: 27622347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.
    Mammina C; Bonura C; Di Bernardo F; Aleo A; Fasciana T; Sodano C; Saporito MA; Verde MS; Tetamo R; Palma DM
    Euro Surveill; 2012 Aug; 17(33):. PubMed ID: 22913977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.
    Marchaim D; Chopra T; Pogue JM; Perez F; Hujer AM; Rudin S; Endimiani A; Navon-Venezia S; Hothi J; Slim J; Blunden C; Shango M; Lephart PR; Salimnia H; Reid D; Moshos J; Hafeez W; Bheemreddy S; Chen TY; Dhar S; Bonomo RA; Kaye KS
    Antimicrob Agents Chemother; 2011 Feb; 55(2):593-9. PubMed ID: 21115786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem non-susceptibility of
    Koppe U; von Laer A; Kroll LE; Noll I; Feig M; Schneider M; Claus H; Eckmanns T; Abu Sin M
    Antimicrob Resist Infect Control; 2018; 7():71. PubMed ID: 29992016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.
    Malli E; Florou Z; Tsilipounidaki K; Voulgaridi I; Stefos A; Xitsas S; Papagiannitsis CC; Petinaki E
    J Microbiol Methods; 2018 Oct; 153():35-39. PubMed ID: 30144479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
    Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Noori Goodarzi N; Solgi H; Badmasti F
    Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):74. PubMed ID: 34688302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Chemical Changes in Laboratory-Induced Colistin-Resistant
    Pruss A; Kwiatkowski P; Łopusiewicz Ł; Masiuk H; Sobolewski P; Fijałkowski K; Sienkiewicz M; Smolak A; Giedrys-Kalemba S; Dołęgowska B
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
    Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
    Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
    Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
    Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of carbapenem- and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India.
    Manohar P; Shanthini T; Ayyanar R; Bozdogan B; Wilson A; Tamhankar AJ; Nachimuthu R; Lopes BS
    J Med Microbiol; 2017 Jul; 66(7):874-883. PubMed ID: 28671537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.